咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Novel 1,3,4-(thiadiazol-2-ylam... 收藏

Novel 1,3,4-(thiadiazol-2-ylamino) methyl-5-(pyridin-4-yl)-1,3,4-oxadiazol-2-thiones: synthesis, docking and antimycobacterial testing

Novel 1,3,4-(thiadiazol-2-ylamino) methyl-5-(pyridin-4-yl)-1,3,4-oxadiazol-2-thiones: synthesis, docking and antimycobacterial testing

作     者:Trupti S. Chitre Santosh Panda Shital M Patil Aparna S. Chothe G Vignesh M. K. Kathiravan 

作者机构:Dept.of Pharmaceutical Chemistry (PGwing) AISSMS College of Pharmacy Kennedy Road Near RTO Pune-411001 Maharashtra India. 

出 版 物:《Advances in Biological Chemistry》 (生物化学进展(英文))

年 卷 期:2011年第1卷第2期

页      面:7-14页

学科分类:07[理学] 0703[理学-化学] 

主  题:Mannich Base Oxadiazole Thiadiazole Antimycobacterial Docking 

摘      要:In the present study, a novel series of Mannich bases of 3-substituted 5-(pyridin-4-yl)-1,3, 4-oxadiazol-2-thione derivatives were synthesized. Docking study was performed to rationalize the possible interactions between the synthesized com-pounds and active site of 14DM. The test compounds were screened for antimycobacterial activity using Middlebrook 7H9 medium against M. tuberculosis H37Rv (ATCC 27294) as well as Isoniazid (INH) resistant clinical strain. Among the series 5c and 5a are found to be most potent (susceptible) while the compound 5f did not show activity against M. tuberculosis H37Rv (resistant). The SAR study reveals the importance of substitutions at para position for good activity.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分